{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:13:49Z","timestamp":1770326029115,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Forensic and Legal Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jflm.2022.102388","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T13:44:33Z","timestamp":1654609473000},"page":"102388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Sensitive detection and primary metabolism analysis of flualprazolam in blood"],"prefix":"10.1016","volume":"90","author":[{"given":"Jiang","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5226-8952","authenticated-orcid":false,"given":"Yanjun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jflm.2022.102388_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chroma.2012.12.049","article-title":"New challenges and innovation in forensic toxicology: focus on the \"new psychoactive substances","volume":"1287","author":"Favretto","year":"2013","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jflm.2022.102388_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/dta.1610","article-title":"New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?","volume":"6","author":"Vidal Gine","year":"2014","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.jflm.2022.102388_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dta.1628","article-title":"Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics","volume":"6","author":"Moosmann","year":"2014","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.jflm.2022.102388_bib4","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1007\/s00216-017-0441-4","article-title":"Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review","volume":"409","author":"Pasin","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jflm.2022.102388_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.9740\/mhc.2019.05.133","article-title":"Flubromazolam overdose: a review of a new designer benzodiazepine and the role of flumazenil","volume":"9","author":"Bohnenberger","year":"2019","journal-title":"ment health clin"},{"key":"10.1016\/j.jflm.2022.102388_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/15563650.2015.1112907","article-title":"Flubromazolam - a new life-threatening designer benzodiazepine","volume":"54","author":"Lukasik-Glebocka","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jflm.2022.102388_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/15563650.2011.645952","article-title":"Legal Highs' - novel and emerging psychoactive drugs: a chemical overview for the toxicologist","volume":"50","author":"Gibbons","year":"2012","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jflm.2022.102388_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11419-015-0277-6","article-title":"Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites","volume":"33","author":"Huppertz","year":"2015","journal-title":"Forensic Toxicol"},{"key":"10.1016\/j.jflm.2022.102388_bib9","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/jat\/bkz063","article-title":"Validation of an LC-MS\/MS method for the quantification of 13 designer benzodiazepines in blood","volume":"43","author":"Mei","year":"2019","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.jflm.2022.102388_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/15563650.2018.1506130","article-title":"Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project","volume":"57","author":"Backberg","year":"2019","journal-title":"Clin Toxicol"},{"issue":"1","key":"10.1016\/j.jflm.2022.102388_bib11","first-page":"1","article-title":"Identification of the designer benzodiazepine 8-chloro-6-(2-fluorophenyl)-1-methyl-4H- 1,2,4 triazolo 4,3-a 1,4 benzo diazepine (flualprazolam) in an anesthesia robbery case","volume":"38","author":"Qian","year":"2019","journal-title":"Forensic Toxicol"},{"issue":"1","key":"10.1016\/j.jflm.2022.102388_bib12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2953","article-title":"Flualprazolam: report of an outbreak of a new psychoactive substance in adolescents","volume":"146","author":"Blumenberg","year":"2020","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jflm.2022.102388_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11419-013-0187-4","article-title":"Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine","volume":"31","author":"Moosmann","year":"2013","journal-title":"Forensic Toxicol"},{"issue":"7","key":"10.1016\/j.jflm.2022.102388_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/dta.2182","article-title":"Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain","volume":"9","author":"Fabregat-Safont","year":"2017","journal-title":"Drug Test Anal"},{"issue":"29","key":"10.1016\/j.jflm.2022.102388_bib15","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1007\/s00216-016-9969-y","article-title":"Guilty by dissociation-development of gas chromatography-mass spectrometry (GC-MS) and other rapid screening methods for the analysis of 13 diphenidine-derived new psychoactive substances (NPSs)","volume":"408","author":"Geyer","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jflm.2022.102388_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jat\/bkaa098","article-title":"Quantification of flualprazolam in blood by LC-MS-MS: a case series of nine deaths[J]","volume":"45","author":"Kathleen","year":"2021","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.jflm.2022.102388_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/dta.2211","article-title":"The emergence of new psychoactive substance (NPS) benzodiazepines: a review","volume":"10","author":"Manchester","year":"2018","journal-title":"Drug Test Anal"},{"issue":"5","key":"10.1016\/j.jflm.2022.102388_bib18","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/1556-4029.14013","article-title":"Hair analysis for drug-facilitated crime: the critical role of hair growth rate","volume":"64","author":"Koren","year":"2019","journal-title":"J Forensic Sci"},{"issue":"1","key":"10.1016\/j.jflm.2022.102388_bib19","article-title":"Drug-facilitated crime caused by drinks or foods","volume":"8","author":"Gharedaghi","year":"2018","journal-title":"Egyptian J Forensic Sci"},{"issue":"4","key":"10.1016\/j.jflm.2022.102388_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.annemergmed.2014.12.019","article-title":"Overdose of etizolam: the abuse and rise of a benzodiazepine analog","volume":"65","author":"O'Connell","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jflm.2022.102388_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2035492","article-title":"Analytical methods used for the detection and quantification of benzodiazepines","volume":"11","author":"Qriouet","year":"2019","journal-title":"J Anal Methods Chem"},{"issue":"1","key":"10.1016\/j.jflm.2022.102388_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/dta.2203","article-title":"Flubromazolam - basic pharmacokinetic evaluation of a highly potent designer benzodiazepine","volume":"10","author":"Huppertz","year":"2018","journal-title":"Drug Test Anal"},{"issue":"13","key":"10.1016\/j.jflm.2022.102388_bib23","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem"},{"issue":"8","key":"10.1016\/j.jflm.2022.102388_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/11080583","article-title":"1,4-Benzodiazepine N-Nitrosoamidines: useful intermediates in the synthesis of tricyclic benzodiazepines","volume":"11","author":"Fustero","year":"2006","journal-title":"Molecules"},{"key":"10.1016\/j.jflm.2022.102388_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/dta.2046","article-title":"Identification of a new psychoactive substance in seized material: the synthetic opioid N-phenyl-N-[1-(2-phenethyl)piperidin-4-yl]prop--enamide (Acrylfentanyl) [J]","volume":"9","author":"Breindahl","year":"2017","journal-title":"Drug Test Anal"}],"container-title":["Journal of Forensic and Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X22000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X22000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:17:46Z","timestamp":1761697066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1752928X22000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":25,"alternative-id":["S1752928X22000865"],"URL":"https:\/\/doi.org\/10.1016\/j.jflm.2022.102388","relation":{},"ISSN":["1752-928X"],"issn-type":[{"value":"1752-928X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensitive detection and primary metabolism analysis of flualprazolam in blood","name":"articletitle","label":"Article Title"},{"value":"Journal of Forensic and Legal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jflm.2022.102388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102388"}}